Skip to main content

Table 1 Organ at risk dose objectives

From: A treatment planning study comparing tomotherapy, volumetric modulated arc therapy, Sliding Window and proton therapy for low-risk prostate carcinoma

Organ

Dose

Volume (in % or in ccm as absolute volume for femoral heads)

Rectum [14]

10Gy

–a

30Gy

<60 %

50Gy

<50 %

60Gy

<35 %

65Gy

<25 %

70Gy

<20 %

75Gy

<15 %

Urinary bladder [15]

10Gy

–a

30Gy

–a

50Gy

<60 %

65Gy

<50 %

70Gy

<35 %

75Gy

<25 %

Femoral heads [13]

50Gy

<5 %

40Gy

≤1ccm

  1. Abbreviations: a-the dose-volume limit is not defined in the QUANTEC reports